Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jun-24 6:27 PM View:  | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | 54% 11.09K to 17.05K | |
| 05-Mar-24 8:08 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 20,357 | -- | -- | 39% 51.57K to 71.93K | |
| 05-Mar-24 8:08 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 4,768 | $53.76 | $256,328.00 | (7%) 71.93K to 67.16K | |
| 06-Sep-23 5:51 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 05-Sep-23 | Sale | 6,000 | $37.96 | $227,760.00 | (10%) 57.28K to 51.28K | |
| 21-Jun-23 6:17 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-23 | Sale | 305 | $48.20 | $14,701.00 | (< 1%) 57.59K to 57.28K | |
| 05-Jun-23 6:02 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Jun-23 | Grant | 4,216 | -- | -- | 61% 6.87K to 11.09K | |
| 03-Mar-23 10:00 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-23 | Grant | 24,663 | -- | -- | 68% 36.34K to 61.01K | |
| 03-Mar-23 10:00 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-23 | Sale | 3,664 | $45.25 | $165,796.00 | (6%) 61.01K to 57.34K | |
| 22-Jun-22 7:27 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-22 | Sale | 295 | $54.78 | $16,160.10 | (< 1%) 36.45K to 36.16K | |
| 03-Mar-22 6:11 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-22 | Grant | 14,000 | -- | -- | 56% 25.03K to 39.03K | |
| 03-Mar-22 6:11 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-22 | Sale | 2,713 | $66.62 | $180,740.00 | (7%) 39.03K to 36.32K | |
| 07-Feb-22 6:54 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Feb-22 | Grant | 6,869 | -- | -- | 100% 0 to 6.87K | |
| 18-Oct-21 6:58 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 14-Oct-21 | Market Sale | 303 | $81.14 | $24,585.40 | (1%) 25.33K to 25.03K | 1% |
| 08-Jul-21 11:56 AM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-Jul-21 | Market Sale | 375 | $91.53 | $34,323.80 | (1%) 25.71K to 25.33K | 2% |
| 23-Jun-21 5:55 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 21-Jun-21 | Market Sale (Planned) | 572 | $94.96 | $54,317.10 | (2%) 26.28K to 25.71K | < 1% |
| 23-Jun-21 5:55 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-21 | Market Sale | 437 | $94.63 | $41,353.30 | (2%) 26.72K to 26.28K | (< 1%) |
| 10-May-21 6:10 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 07-May-21 | Market Sale (Planned) | 393 | $113.67 | $44,672.30 | (1%) 27.11K to 26.72K | (< 1%) |
| 10-May-21 6:10 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-May-21 | Market Sale | 307 | $113.68 | $34,899.80 | (1%) 27.42K to 27.11K | (< 1%) |
| 21-Apr-21 8:07 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Apr-21 | Market Sale (Planned) | 396 | $104.28 | $41,294.90 | (1%) 27.81K to 27.42K | (< 1%) |
| 03-Mar-21 8:42 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 02-Mar-21 | Market Sale (Planned) | 707 | $138.16 | $97,679.10 | (2%) 28.52K to 27.81K | |
| 03-Mar-21 8:42 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-21 | Grant | 10,136 | -- | -- | 49% 20.85K to 30.99K | |
| 03-Mar-21 8:42 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-21 | Market Sale | 2,470 | $138.17 | $341,280.00 | (8%) 30.99K to 28.52K | |
| 16-Oct-20 7:20 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 14-Oct-20 | Market Sale | 220 | $88.00 | $19,360.00 | (< 1%) 23.59K to 23.37K | (96%) |
| 08-Jul-20 12:29 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-Jul-20 | Payment of Exercise | 260 | $86.75 | $22,555.00 | (1%) 23.85K to 23.59K | (99%) |
| 22-Jun-20 1:47 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-20 | Payment of Exercise | 303 | $78.22 | $23,700.70 | (1%) 24.15K to 23.85K | (121%) |
| 03-Feb-21 8:04 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 03-Jun-20 | Market Sale | 2,516 | $74.69 | $187,920.00 | (11%) 23.37K to 20.85K | (105%) |
| 08-May-20 8:11 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-May-20 | Payment of Exercise | 209 | $66.26 | $13,848.30 | (< 1%) 24.36K to 24.15K | (161%) |
| 21-Apr-20 3:31 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Apr-20 | Payment of Exercise | 210 | $58.57 | $12,299.70 | (< 1%) 24.57K to 24.36K | (195%) |
| 03-Mar-20 8:02 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-20 | Grant | 11,087 | -- | -- | 77% 14.31K to 25.4K | |
| 03-Mar-20 8:02 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-20 | Payment of Exercise | 824 | $56.08 | $46,209.90 | (3%) 25.4K to 24.57K | (208%) |
| 16-Oct-19 7:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 14-Oct-19 | Grant | 1,208 | -- | -- | 9% 13.1K to 14.31K | |
| 09-Jul-19 7:40 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-Jul-19 | Payment of Exercise | 260 | $59.51 | $15,472.60 | (2%) 13.36K to 13.1K | (190%) |
| 21-Jun-19 8:05 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-19 | Grant | 3,500 | -- | -- | 35% 9.86K to 13.36K |